Immuron Ltd (IMRN)
2.36
-0.10
(-3.87%)
USD |
NASDAQ |
Apr 19, 16:00
2.36
0.00 (0.00%)
After-Hours: 20:00
Immuron Shareholders Equity (Quarterly): 11.94M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 11.94M |
December 31, 2023 | 11.94M |
June 30, 2023 | 12.98M |
December 31, 2022 | 14.47M |
December 31, 2022 | 14.47M |
June 30, 2022 | 15.94M |
December 31, 2021 | 17.53M |
December 31, 2021 | 17.53M |
June 30, 2021 | 19.46M |
December 31, 2020 | 21.94M |
December 31, 2020 | 21.94M |
Date | Value |
---|---|
June 30, 2020 | 3.878M |
December 31, 2019 | 4.796M |
December 31, 2019 | 4.796M |
June 30, 2019 | 5.148M |
December 31, 2018 | 5.055M |
December 31, 2018 | 5.055M |
June 30, 2018 | 6.200M |
December 31, 2017 | 3.888M |
December 31, 2017 | 3.888M |
June 30, 2017 | 5.052M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.878M
Minimum
Jun 2020
21.94M
Maximum
Dec 2020
13.25M
Average
14.47M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Mesoblast Ltd | 501.84M |
CERo Therapeutics Holdings Inc | -- |
Alterity Therapeutics Ltd | 26.42M |
Kazia Therapeutics Ltd | 7.976M |
Immutep Ltd | 22.88M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.55M |
Total Liabilities (Quarterly) | 1.605M |
Current Ratio | 8.519 |